Arquivos de Asma, Alergia e Imunologia
https://aaai-asbai.org.br/article/doi/10.5935/2526-5393.20210063
Arquivos de Asma, Alergia e Imunologia
Comunicação Clínica e Experimental

Apresentação atípica de síndrome de hiper-IgM ligada ao X simulando doença inflamatória intestinal

Atypical presentation of X-linked hyper-IgM syndrome simulating inflammatory bowel disease

Nara Lillian Lima Cardoso; François Loiola Ponte de Souza; Hildenia Baltasar Ribeiro Nogueira; Janáira Fernandes Severo Ferreira; Tábata Takahashi França; Antonio Condino-Neto

Downloads: 0
Views: 46

Resumo

Relatamos o caso de um paciente do sexo masculino, que iniciou quadro de úlceras em trato gastrointestinal, associado a febre recorrente e diarreia com muco e sangue aos 10 meses de vida, suspeitado inicialmente de doença inflamatória intestinal, no entanto, não apresentou melhora do quadro com terapia imunossupressora, sendo realizada investigação para erro inato da imunidade. Nos exames laboratoriais, apresentou níveis baixos de IgG e IgA e níveis elevados de IgM e neutropenia persistente. Diante disso, foi realizado teste genético que confirmou diagnóstico de síndrome de hiper-IgM ligada ao X. Os erros inatos da imunidade podem se manifestar com doenças do trato gastrointestinal, de forma relativamente frequente, devendo entrar como diagnóstico diferencial de diarreia crônica. Inclusa nesse grupo de doenças, as síndromes de hiper-IgM constituem um grupo heterogêneo de doenças, possuindo em comum níveis significativamente baixos ou ausentes de IgG e IgA e níveis normais ou elevados de IgM, o que predispõe a infecções e febre recorrente; além de outras alterações laboratoriais, como neutropenia, que pode estar associada a úlceras no trato gastrointestinal e proctite, simulando apresentação clínica de doença inflamatória intestinal. Para o paciente relatado, foi iniciada terapia com imunoglobulinas de forma periódica, além de antibioticoprofilaxia para infecções, evoluindo com resposta clínica satisfatória. O artigo possui objetivo principal de alertar para o diagnóstico diferencial de erros inatos da imunidade diante do quadro apresentado, visando o diagnóstico precoce e a instituição da terapia adequada.

Palavras-chave

Doenças da imunodeficiência primária, doenças do sistema imunitário, síndrome de imunodeficiência com hiperIgM tipo 1.

Abstract

We report the case of a male patient, who started with ulcers in the gastrointestinal tract, associated with recurrent fever and diarrhea with mucus and blood at 10 months of life, initially suspected of inflammatory bowel disease, however, he did not improve the condition with immunosuppressive therapy, being investigated for inborn error of immunity. In laboratory tests, he had low levels of IgG and IgA and high levels of IgM and persistent neutropenia. Therefore, a genetic test was performed and confirmed the diagnosis of X-linked hyper IgM syndrome. Inborn errors of immunity can manifest relatively frequently with diseases of the gastrointestinal tract, and should be included as a differential diagnosis of chronic diarrhea. Included in this group of diseases, hyper-IgM syndromes constitute a heterogeneous group of diseases, having in common significantly low or absent levels of IgG and IgA and normal or high levels of IgM, which predispose to infections and recurrent fever; in addition to other laboratory alterations, such as neutropenia, which may be associated with ulcers in the gastrointestinal tract and proctitis, simulating the clinical presentation of inflammatory bowel disease. For the reported patient, therapy with immunoglobulins was started periodically, in addition to antibiotic prophylaxis for infections, evolving with a satisfactory clinical response. The main objective of the article is to alert to the differential diagnosis of inborn errors of immunity in view of the presented condition, aiming at early diagnosis and the institution of adequate therapy.

Keywords

Primary immunodeficiency diseases, immune system diseases, hyper-IgM immunodeficiency syndrome type 1.

Referências

1. Amaya-Uribe L, Rojas M, Azizi G, Anaya JM, Gershwin ME. Primary immunodeficiency and autoimmunity: A comprehensive review. J Autoimmun. 2019 May;99:52-72.

2. Wu J, Zhong W, Yin Y, Zhang H. Primary immunodeficiency disease: a retrospective study of 112 Chinese children in a single tertiary care center. BMC Pediatr. 2019 Nov 4;19(1):410.

3. Justiz Vaillant AA, Qurie A. Immunodeficiency. 2021 Jun 30. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2021 Jan–. PMID: 29763203.

4. Benkerrou M, Gougeon ML, Griscelli C, Fischer A. Hypogammaglobulinémie G et A avec hypergammaglobulinémie M. A propos de 12 observations [Hypogammaglobulinemia G and A with hypergammaglobulinemia M. Apropos of 12 cases]. Arch Fr Pediatr. 1990 May;47(5):345-9. French. PMID: 2369267.

5. Agarwal S, Cunningham-Rundles C. Gastrointestinal Manifestations and Complications of Primary Immunodeficiency Disorders. Immunol Allergy Clin North Am. 2019 Feb;39(1):81-94. doi: 10.1016/j.iac.2018.08.006.

6. de la Morena MT. Clinical Phenotypes of Hyper-IgM Syndromes. Clinical Management Review. 2016;1023-34.

7. de la Morena MT. Clinical Phenotypes of Hyper-IgM Syndromes. J Allergy Clin Immunol Pract. 2016 Nov-Dec;4(6):1023-1036. doi: 10.1016/j.jaip.2016.09.013.

8. Saiki O, Tanaka T, Wada Y, Uda H, Inoue A, Katada Y, et al. Signaling through CD40 rescues IgE but not IgG or IgA secretion in X-linked immunodeficiency with hyper-IgM. J Clin Invest. 1995 Feb;95(2):510-4. doi: 10.1172/JCI117692.

9. Yazdani R, Fekrvand S, Shahkarami S, Azizi G, Moazzami B, Abolhassani H, et al. The hyper IgM syndromes: Epidemiology, pathogenesis, clinical manifestations, diagnosis and management. Clin Immunol. 2019 Jan;198:19-30. doi: 10.1016/j.clim.2018.11.007.

10. Kim D, Shin JA, Han SB, Chung NG, Jeong DC. Pneumocystis jirovecii pneumonia as an initial manifestation of hyper-IgM syndrome in an infant: A case report. Medicine (Baltimore). 2019 Feb;98(7):e14559. doi: 10.1097/MD.0000000000014559.

11. Notarangelo LD, Duse M, Ugazio AG. Immunodeficiency with hyperIgM (HIM). Immunodefic Rev. 1992;3(2):101-21. PMID: 1554497.

12. Ameratunga R, Woon ST, Koopmans W, French J. Cellular and molecular characterisation of the hyper immunoglobulin M syndrome associated with congenital rubella infection. J Clin Immunol. 2009;29:99.

13. Groeneweg M, Hartwig NG, Poerink-Stockschläder AB, Schweizer JJ, Bijleveld CM, Bredius RG. Twee kinderen met ernstige, recidiverende infecties en het X-gebonden hyper-IgM-syndroom [Two children with severe recurrent infections and the X-linked hyper-IgM syndrome]. Ned Tijdschr Geneeskd. 2003 May 24;147(21):1024-8. Dutch. PMID: 12811975.

14. Yazdani R, Fekrvand S, Shahkarami S, Azizi G, Moazzami B, Abolhassani H, Aghamohammadi A. The hyper IgM syndromes: Epidemiology, pathogenesis, clinical manifestations, diagnosis and management. Clin Immunol. 2019 Jan;198:19-30. doi: 10.1016/j.clim.2018.11.007.

15. Atarod L, Aghamohammadi A, Moin M, Kanegane H, Rezaei N, Rezaei Kalantari K, et al. Successful management of neutropenia in a patient with CD40 ligand deficiency by immunoglobulin replacement therapy. Iran J Allergy Asthma Immunol. 2007 Mar;6(1):37-40. PMID: 17303928.

16. Winkelstein JA, Marino MC, Ochs H, Fuleihan R, Scholl PR, Geha R, et al. The X-linked hyper-IgM syndrome: clinical and immunologic features of 79 patients. Medicine (Baltimore). 2003 Nov;82(6):373- 84. doi: 10.1097/01.md.0000100046.06009.b0.

17. Levy J, Espanol-Boren T, Thomas C, Fischer A, Tovo P, Bordigoni P, et al. Clinical spectrum of X-linked hyper-IgM syndrome. J Pediatr. 1997 Jul;131(1 Pt 1):47-54. doi: 10.1016/s0022-3476(97)70123-9.

18. Van Hoeyveld E, Zhang PX, De Boeck K, Fuleihan R, Bossuyt X. Hyper-immunoglobulin M syndrome caused by a mutation in the promotor for CD40L. Immunology. 2007 Apr;120(4):497-501. doi: 10.1111/j.1365-2567.2006.02520.x. Epub 2007 Jan 17. PMID: 17244160.

19. Lougaris V, Badolato R, Ferrari S, Plebani A. Hyper immunoglobulin M syndrome due to CD40 deficiency: clinical, molecular, and immunological features. Immunol Rev. 2005 Feb;203:48-66. doi: 10.1111/j.0105-2896.2005.00229.x. PMID: 15661021.

20. Wang WC, Cordoba J, Infante AJ, Conley ME. Successful treatment of neutropenia in the hyper-immunoglobulin M syndrome with granulocyte colony-stimulating factor. Am J Pediatr Hematol Oncol. 1994 May;16(2):160-3. PMID: 7513136.


Submetido em:
06/07/2021

Aceito em:
12/10/2021

6a1496eba95395453e1c90d8 aaai Articles
Links & Downloads

Arq Asma Alerg Imunol

Share this page
Page Sections